Dai Z - Search Results

1

Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.

Xiao JJ, Foraker AB, Swaan PW, Liu S, Huang Y, Dai Z, Chen J, Sadée W, Byrd J, Marcucci G, Chan KK. Xiao JJ, et al. Among authors: dai z. J Pharmacol Exp Ther. 2005 Apr;313(1):268-76. doi: 10.1124/jpet.104.072033. Epub 2005 Jan 5. J Pharmacol Exp Ther. 2005. PMID: 15634944

2

Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines.

Xiao JJ, Huang Y, Dai Z, Sadée W, Chen J, Liu S, Marcucci G, Byrd J, Covey JM, Wright J, Grever M, Chan KK. Xiao JJ, et al. Among authors: dai z. J Pharmacol Exp Ther. 2005 Jul;314(1):467-75. doi: 10.1124/jpet.105.083956. Epub 2005 Apr 15. J Pharmacol Exp Ther. 2005. PMID: 15833893

3

Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1.

Huang Y, Blower PE, Yang C, Barbacioru C, Dai Z, Zhang Y, Xiao JJ, Chan KK, Sadée W. Huang Y, et al. Among authors: dai z. Pharmacogenomics J. 2005;5(2):112-25. doi: 10.1038/sj.tpj.6500297. Pharmacogenomics J. 2005. PMID: 15668728

4

Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.

Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P, Zheng X, Sadee W, Sun D. Cao X, et al. Among authors: dai z. Cancer Chemother Pharmacol. 2007 Mar;59(4):495-505. doi: 10.1007/s00280-006-0291-9. Epub 2006 Aug 12. Cancer Chemother Pharmacol. 2007. PMID: 16906425

5

5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer).

Dai Z, Liu S, Marcucci G, Sadee W. Dai Z, et al. Biochem Biophys Res Commun. 2006 Dec 15;351(2):455-61. doi: 10.1016/j.bbrc.2006.10.055. Epub 2006 Oct 18. Biochem Biophys Res Commun. 2006. PMID: 17064661

6

Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

Huang Y, Dai Z, Barbacioru C, Sadée W. Huang Y, et al. Among authors: dai z. Cancer Res. 2005 Aug 15;65(16):7446-54. doi: 10.1158/0008-5472.CAN-04-4267. Cancer Res. 2005. PMID: 16103098

7

Pharmacogenetics/genomics and personalized medicine.

Sadée W, Dai Z. Sadée W, et al. Among authors: dai z. Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R207-14. doi: 10.1093/hmg/ddi261. Hum Mol Genet. 2005. PMID: 16244319 Review.

8

Prediction of anticancer drug potency from expression of genes involved in growth factor signaling.

Dai Z, Barbacioru C, Huang Y, Sadée W. Dai Z, et al. Pharm Res. 2006 Feb;23(2):336-49. doi: 10.1007/s11095-005-9260-y. Epub 2006 Jan 26. Pharm Res. 2006. PMID: 16425089

9

Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-.

Dai Z, Huang Y, Sadee W, Blower P. Dai Z, et al. J Med Chem. 2007 Apr 19;50(8):1896-906. doi: 10.1021/jm060960h. Epub 2007 Mar 17. J Med Chem. 2007. PMID: 17367118

10

Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.

Huang Y, Blower PE, Liu R, Dai Z, Pham AN, Moon H, Fang J, Sadée W. Huang Y, et al. Among authors: dai z. Pharm Res. 2007 Sep;24(9):1702-12. doi: 10.1007/s11095-007-9300-x. Epub 2007 Apr 25. Pharm Res. 2007. PMID: 17457659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,204 results

Search Page

Filters